Therapeutic Asset Ratings
9,928 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Anti-Cd19 Car-Expressing T-Lymphocytes Ic19/1563
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Anti-Cd83 Car T-Cells
Acute Myeloid Leukemia
Roswell Park Cancer Institute
P1
CC
(43)
Autologous Anti-Psca-Car-4-1Bb/Tcrzeta-Cd19T-Expressing T-Lymphocytes
Metastatic Prostate Carcinoma
City of Hope Medical Center
P1
CC
(43)
Autologous Anti-Psca-Car-4-1Bb/Tcrzeta-Cd19T-Expressing T-Lymphocytes
Prostate Cancer
City of Hope Medical Center
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Follicular Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Mantle Cell Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Marginal Zone Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Bone Marrow Derived Cd34+ Hspcs Electroporated With Bcl11A Enhancer Targeting Cas9 Ribonucleoprotein
Beta-Thalassemia Major
Daniel Bauer
P1
CC
(43)
Autologous Car19 T Lymphocytes
Non-Hodgkin Lymphoma
Institute of Hematology and Blood Transfusion, Czech Republic
P1
CC
(43)
Autologous Car19 T Lymphocytes
B-Cell Acute Lymphoblastic Leukemia
Institute of Hematology and Blood Transfusion, Czech Republic
P1
CC
(43)
Autologous Car.Cd30 Ebv Specific-Ctls
Hodgkins Lymphoma
Baylor College of Medicine
P1
CC
(43)
Autologous Car-T Cell Therapy Expressing The Baff-Ligand.
Plasma Cell Myeloma
Luminary Therapeutics
P1
CC
(43)
Autologous Ccr4 Car T Cells
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Enteropathy-Associated T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Neoplasm Of Mature T-Cells Or NK-Cells
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Subcutaneous Panniculitis-Like T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Acute Biphenotypic Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Adult Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Acute Myeloid Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
CD4+/CD56+ Hematodermic Neoplasm
City of Hope Medical Center
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Autoimmune Hemolytic Anemia
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Idiopathic Inflammatory Myopathy
Beijing Boren Hospital
P1
CC
(43)
Showing 1051 to 1075 of 9,928 assets
Previous
Page 43 of 398
Next
